CanaDan Bio ApS: Financial statements 2024
CVR: 40896813
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
CanaDan Bio ApS (CVR 40896813) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -2,160 and a net result of DKK 3,483 compared with DKK 8,775 the year before. Equity in the 2024 report amounted to DKK 23,711. The solvency ratio was 3.2%.
- Gross Profit
- DKK -2,160
- Profit/Loss
- DKK 3,483
- Equity
- DKK 23,711
- Total Assets
- DKK 735,623
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -2K | 3K | 24K | - |
| 2023 | - | -1K | 9K | 20K | - |
| 2022 | 0 | -3K | 6K | 11K | - |
| 2021 | 0 | -47K | -11K | 5K | - |
| 2020 | 0 | -23K | -24K | 16K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
CanaDan Bio ApS has published its annual report for 2023. Gross profit came to DKK -1,200, and the net result was DKK 8,775.
About CanaDan Bio ApS
CanaDan Bio ApS is a Danish company of the type Anpartsselskab based in Vanløse, founded in 2019. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Lionel le Lay. The company is owned by PYTHOR ApS and Megapol ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -1,395 and a net result of DKK 4,372 compared with DKK 3,483 the year before. Equity in the 2025 report amounted to DKK 28,083.